Patent Yard Sign in
Expired European patentEurope

Pharmaceutical formulation comprising a 2[[(2-pyridinyl)methyl]sulfinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such formulation

EP 1061920 B1 · Applicant: A/S GEA Farmaceutisk Fabrik

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 17, 1999 and granted June 12, 2002. A European patent lasts at most 20 years from filing, so its term ended March 17, 2019.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 17, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 17, 1999
PublishedDecember 27, 2000
GrantedJune 12, 2002
Term endedMarch 17, 2019
Application numberEP 99907346
Classification (CPC)A61P1/04 +2 more

Timeline

Timeline From EPO dates

2000200220042006200820102012201420162018Application filedMarch 17, 1999PublishedDec 27, 2000Patent grantedJune 12, 2002Term endedMarch 17, 2019

Sources & verification